Article
Immunogenicity profile in African green monkeys of a vaccine candidate based on a mutated form of human Interleukin-15.
BMC immunology - 18 Dec 2021
Rodríguez-Álvarez Yunier, Batista-Roche Lino Gerardo, Llopiz-Arzuaga Alexey, Puente-Pérez Pedro, Martínez-Castillo Rafael, Castro-Velazco Jorge, Santos-Savio Alicia
Abstract excerpt
BACKGROUND: Interleukin (IL)-15 is a proinflammatory T-cell growth factor overexpressed in several autoimmune diseases such as rheumatoid arthritis. Our initial strategy to neutralize the increased levels of IL-15 consisted in a vaccine candidate based on the recombinant modified human IL-15 (mhIL-15) mixed with the alum adjuvant. A previous study in non-human primates Macaca fascicularis has shown that...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
